Stockscreener 앱 받기
9.18
4.42%
-0.425
시간 외 거래:
9.47
0.29
+3.16%
전일 마감가:
$9.605
열려 있는:
$9.57
하루 거래량:
1.18M
Relative Volume:
1.45
시가총액:
$273.09M
수익:
$34.33M
순이익/손실:
$-23.14M
주가수익비율:
-11.11
EPS:
-0.8262
순현금흐름:
$-13.82M
1주 성능:
-20.38%
1개월 성능:
-36.03%
6개월 성능:
-18.04%
1년 성능:
-31.39%
1일 변동 폭
$9.00
$9.57
1주일 범위
$9.00
$11.89
52주 변동 폭
$8.63
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
명칭
Clearpoint Neuro Inc
전화
(949) 900-6833
주소
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
9.18 | 285.73M | 34.33M | -23.14M | -13.82M | -0.8262 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2023-10-24 | 개시 | Stifel | Buy |
| 2023-02-16 | 재개 | B. Riley Securities | Buy |
| 2022-04-05 | 재개 | B. Riley Securities | Buy |
| 2021-03-18 | 개시 | Lake Street | Buy |
| 2020-07-17 | 개시 | B. Riley FBR | Buy |
모두보기
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript - Insider Monkey
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN
Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and Synergies - TipRanks
ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses - simplywall.st
Intuitive Surgical Stock: Buy, Sell, or Hold? - AOL.com
ClearPoint Neuro Q4 Earnings Call Highlights - MarketBeat
ClearPoint Neuro (NASDAQ:CLPT) Given New $20.00 Price Target at B. Riley Financial - MarketBeat
ClearPoint Neuro (CLPT) Sees Raised Price Target from B. Riley S - GuruFocus
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - Seeking Alpha
Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $18, Keeps Buy Rating - marketscreener.com
ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN
ClearPoint Neuro (CLPT) Surpasses Q4 Revenue Expectations with S - GuruFocus
Clearpoint Neuro earnings missed by $0.08, revenue topped estimates - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
CLPT Revenue Rises, Losses Widen Amid Cautious 2026 Outlook - Bitget
ClearPoint Neuro, Inc. (CLPT) reports Q4 loss, tops revenue estimates - MSN
ClearPoint Neuro, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
ClearPoint Neuro outlines $52M–$56M 2026 revenue target as company advances growth strategy and integrates IRRAS acquisition - MSN
Clearpoint Neuro Charts Aggressive Growth Amid Rising Costs - TipRanks
ClearPoint Neuro (CLPT) Projects Strong Growth for 2026 - GuruFocus
ClearPoint Neuro 2025 Results & 2026 Growth Strategy for Neuro EcosystemNews and Statistics - IndexBox
ClearPoint Neuro (CLPT) Quarterly Earnings Conference Call Transcript - Bitget
CLPT: Record 2025 growth and IRRAS integration set the stage for double-digit expansion in 2026 - TradingView
ClearPoint Neuro (CLPT) Earnings Call Transcript - The Globe and Mail
Earnings call transcript: ClearPoint Neuro Q4 2025 sees revenue growth, stock up - Investing.com
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
ClearPoint Neuro (NASDAQ:CLPT) Posts Quarterly Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
ClearPoint Neuro (NASDAQ: CLPT) expands into neurocritical care - Stock Titan
Clearpoint Neuro Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ClearPoint Neuro Inc. (CLPT) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
ClearPoint Neuro Reports Record 2025 Results, Expands Growth Outlook - TipRanks
ClearPoint Neuro Q4 Revenue Rises; Issues 2026 Revenue Guidance - marketscreener.com
ClearPoint Neuro Q4 revenue rises on IRRAS acquisition - TradingView
CLPT: Record 2025 revenue and IRRAS acquisition set stage for double-digit growth in 2026 - TradingView
ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ClearPoint Neuro (NASDAQ: CLPT) grows 2025 revenue, targets $52–$56M in 2026 - Stock Titan
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results - ACCESS Newswire
Brain-surgery device firm ClearPoint expects $52M–$56M in 2026 sales - Stock Titan
ClearPoint Neuro (CLPT) CFO nets shares after RSU vesting and tax withholding - Stock Titan
ClearPoint Neuro (CLPT) CEO settles 84,829 RSUs, covers taxes in shares - Stock Titan
ClearPoint Neuro (CLPT) CBO settles RSUs, 15,151 shares for taxes - Stock Titan
ClearPoint Neuro (CLPT) COO settles 26,101 RSUs and covers taxes - Stock Titan
ClearPoint Neuro Inc (CLPT) Q4 2025 Earnings Report Preview: Wha - GuruFocus
Boone Capital Management LLC Takes Position in ClearPoint Neuro, Inc. $CLPT - MarketBeat
Clearpoint Neuro Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
MAK Capital (CLPT) reports 1.73M shares, 6.1% stake in ClearPoint - Stock Titan
ClearPoint Neuro (CLPT) CFO settles RSUs and withholds shares for taxes - Stock Titan
[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity - Stock Titan
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025 - marketscreener.com
How Clearpoint Neuro, Inc. (CLPT) Affects Rotational Strategy Timing - Stock Traders Daily
Clearpoint Neuro Inc (CLPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):